Table 1.
Baseline characteristics of patients.
| Number of patients | 92 |
| Mean age, years | 63 ± 13 (19-91) |
| Male,n | 45 |
| Female,n | 47 |
| Cirrhosis etiology,n(%) | |
| Hepatitis C | 39 (42) |
| Hepatitis B | 9 (10) |
| Autoimmune hepatitis | 7 (8) |
| Primary biliary cirrhosis | 8 (9) |
| Alcohol | 3 (4) |
| Nonalcoholic steatohepatitis | 7 (8) |
| Cryptogenic | 13 (14) |
| Others | 4 (5) |
| Causes for admission,n(%) | |
| Edemato-ascitic decompensation | 46 (50) |
| Hepatic encephalopathy | 23 (25) |
| Gastro-intestinal bleeding | 14 (15) |
| Fever | 14 (15) |
| Others | 9 (10) |
| Infection source,n(%) | |
| Pulmonary tract infection | 37 (62) |
| Urinary tract infection | 12 (20) |
| Spontaneous bacterial peritonitis | 14 (23) |
| Skin infection | 5 (8) |
| Multiple sites | 6 (10) |
| Bacteremia | 9 (14) |
| Isolated | 3 (5) |
| Associated to another source | 6 (10) |
| Severity scores | |
| Child-Pugh class (%) | |
| A | 7 |
| B | 61 |
| C | 32 |
| Child-Pugh, mean | 10 ± 2 (6–15) |
| ACLF (%) | |
| Grade 1 | 33 |
| Grade 2 | 32 |
| Grade 3 | 35 |
| MELD score, mean | 18 ± 7 (8-35) |
| APACHE II score, mean | 20 ± 5 (12-34) |
MELD: Model for End-Stage Liver Disease; APACHE II: Acute Physiology and Chronic Health Disease Classification System II; ACLF: Acute-on-chronic liver failure.